CIRM Funded Clinical Trials
Evaluation of Safety and Feasibility of Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV/HIV-CAR) T Cells in People with HIV
Disease Area:
Trial Sponsor:
Beckman Research Institute of City of Hope
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
